Figure 6.
Distinct effect of MEKi and anti-PD-1 on myeloid lesional cells and intralesional lymphoid cells. (A-F) FlowSOM analysis of representative lesion biopsy specimens from lung of BRAFV600ECD11c mice in the indicated experimental groups. Green circle, myeloid compartment; blue circle, lymphoid compartment. (G) Representative immunohistochemistry images of infiltrating T cells (CD8+ and CD4+), and DCs (CD11b+ and CD11c+) in lungs of the different experimental groups. Bars represent 100 µm. (H) Quantification of lesion infiltrating CD8+ and CD4+ T cells in the indicated experimental groups. Data are the means ± SD (n = 9 mice per group); ***P < .001; ****P < .0001; ns, not significant (P > .05), by 1-way ANOVA with Tukey’s post hoc test.

Distinct effect of MEKi and anti-PD-1 on myeloid lesional cells and intralesional lymphoid cells. (A-F) FlowSOM analysis of representative lesion biopsy specimens from lung of BRAFV600ECD11c mice in the indicated experimental groups. Green circle, myeloid compartment; blue circle, lymphoid compartment. (G) Representative immunohistochemistry images of infiltrating T cells (CD8+ and CD4+), and DCs (CD11b+ and CD11c+) in lungs of the different experimental groups. Bars represent 100 µm. (H) Quantification of lesion infiltrating CD8+ and CD4+ T cells in the indicated experimental groups. Data are the means ± SD (n = 9 mice per group); ***P < .001; ****P < .0001; ns, not significant (P > .05), by 1-way ANOVA with Tukey’s post hoc test.

Close Modal

or Create an Account

Close Modal
Close Modal